ClinicalTrials.Veeva

Menu

Hypnotic and Anti-nociceptive Components of Magnesium

U

University of Liege

Status and phase

Unknown
Phase 4

Conditions

Anesthesia

Treatments

Drug: Placebo
Drug: Magnesium sulfate IV

Study type

Interventional

Funder types

Other

Identifiers

NCT05005494
MG-Entropy

Details and patient eligibility

About

The aim of our study is to evaluate the effect of magnesium on the hypnotic effect of propofol.

Full description

The aim of our study is to evaluate the effect of magnesium on the hypnotic effect of propofol. To achieve this, the investigators will analyse the effect of magnesium on the brain concentrations of propofol required to achieve a State Entropy value between 50-60, which corresponds to the recommended depth of anaesthesia. Our study will also evaluate the intraoperative anti- nociceptive effect of magnesium using pupillometry and its two indices, PPI and PRD

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adult > 18 years
  • Patients of both sexes
  • Any patient scheduled for thyroidectomy at the University Hospital of Liege

Exclusion criteria

  • Heart failure with left ventricular ejection fraction < 35
  • Renal insufficiency (clearance < 40 mL/min)
  • Neuromuscular diseases
  • Atrioventricular block
  • Pregnancy

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

20 participants in 2 patient groups, including a placebo group

Magnesium sulfate IV
Active Comparator group
Description:
10 patients scheduled for thyroidectomy
Treatment:
Drug: Magnesium sulfate IV
Placebo
Placebo Comparator group
Description:
10 patients scheduled for thyroidectomy
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Central trial contact

Pierre-Yves Hardy, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems